150 related articles for article (PubMed ID: 9175241)
1. Protein S deficiency and antibodies to protein S in patients with Behçet's disease.
Guermazi S; Hamza M; Dellagi K
Thromb Res; 1997 May; 86(3):197-204. PubMed ID: 9175241
[TBL] [Abstract][Full Text] [Related]
2. Decreased protein S activity in sickle cell disease.
Marfaing-Koka A; Boyer-Neumann C; Wolf M; Leroy-Matheron C; Cynober T; Tchernia G
Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):425-30. PubMed ID: 8414963
[TBL] [Abstract][Full Text] [Related]
3. Further evidence for the presence of anti-protein S autoantibodies in patients with systemic lupus erythematosus.
Guermazi S; Regnault V; Gorgi Y; Ayed K; Lecompte T; Dellagi K
Blood Coagul Fibrinolysis; 2000 Jul; 11(5):491-8. PubMed ID: 10937810
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of protein S by autoantibodies in patients with acquired protein S deficiency.
Sorice M; Arcieri P; Griggi T; Circella A; Misasi R; Lenti L; Di Nucci GD; Mariani G
Thromb Haemost; 1996 Apr; 75(4):555-9. PubMed ID: 8743177
[TBL] [Abstract][Full Text] [Related]
5. A study on thrombophilic factors in Italian Behcet's patients.
Caramaschi P; Poli G; Bonora A; Volpe A; Tinazzi I; Pieropan S; Bambara LM; Biasi D
Joint Bone Spine; 2010 Jul; 77(4):330-4. PubMed ID: 20452800
[TBL] [Abstract][Full Text] [Related]
6. Is there a role for anti-phospholipid-binding protein antibodies in the pathogenesis of thrombosis in Behcet's disease?
Priori R; Conti F; Pittoni V; Garofalo T; Sorice M; Valesini G
Thromb Haemost; 2000 Jan; 83(1):173-4. PubMed ID: 10669174
[No Abstract] [Full Text] [Related]
7. Antithrombin III, protein C and protein S plasma levels in patients with Behçet's disease.
Nalçaci M; Pekçelen Y
J Int Med Res; 1998; 26(4):206-8. PubMed ID: 9818787
[TBL] [Abstract][Full Text] [Related]
8. Failure of the synthetic androgen, danazol, to increase protein S levels and prevent thrombosis in a patient with severe protein S deficiency.
Bower WA; Humphries JE
Haemostasis; 1995; 25(3):144-8. PubMed ID: 7607583
[TBL] [Abstract][Full Text] [Related]
9. Acquired free protein S deficiency associated with multiple myeloma: a case report.
Deitcher SR; Erban JK; Limentani SA
Am J Hematol; 1996 Apr; 51(4):319-23. PubMed ID: 8602634
[TBL] [Abstract][Full Text] [Related]
10. Decreased protein S activity is related to the disease activity of Behcet's disease.
Kwon SR; Lim MJ; Park SG; Moon YS; Park W
Rheumatol Int; 2006 Nov; 27(1):39-43. PubMed ID: 16969634
[TBL] [Abstract][Full Text] [Related]
11. Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease.
Mader R; Ziv M; Adawi M; Mader R; Lavi I
J Rheumatol; 1999 Nov; 26(11):2404-8. PubMed ID: 10555901
[TBL] [Abstract][Full Text] [Related]
12. Right atrial and ventricular thrombi in Behçet's disease: a case report and review of literature.
Gürgün C; Sagcan A; Cinar CS; Yagdi T; Zoghi M; Tekten T; Kultursay H
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):107-10. PubMed ID: 10691105
[TBL] [Abstract][Full Text] [Related]
13. Antiannexin V autoantibody in thrombophilic Behçet's disease.
Aslan H; Pay S; Gok F; Baykal Y; Yilmaz MI; Sengul A; Aydin HI
Rheumatol Int; 2004 Mar; 24(2):77-9. PubMed ID: 14658002
[TBL] [Abstract][Full Text] [Related]
14. Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies--a crucial role for acquired free protein S deficiency.
Ames PR; Tommasino C; Iannaccone L; Brillante M; Cimino R; Brancaccio V
Thromb Haemost; 1996 Aug; 76(2):190-4. PubMed ID: 8865529
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of anticoagulant proteins detection in patients with thrombotic events].
Zheng CC; Wu JS; Ding KY; Li J; Hu HJ; Ding XL; Liu X; Cai XY; Zhu WB
Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):264-7. PubMed ID: 19731829
[TBL] [Abstract][Full Text] [Related]
16. Protein C and protein S activities in Behçet's disease as risk factors of thrombosis.
Lenk N; Ozet G; Alli N; Coban O; Erbaşi S
Int J Dermatol; 1998 Feb; 37(2):124-5. PubMed ID: 9542668
[TBL] [Abstract][Full Text] [Related]
17. Could be serum uric acid a risk factor for thrombosis and/or uveitis in Behcet's disease?
Atıl A; Deniz A
Vascular; 2018 Aug; 26(4):378-386. PubMed ID: 29360007
[TBL] [Abstract][Full Text] [Related]
18. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
[TBL] [Abstract][Full Text] [Related]
19. Protein S and protein C anticoagulant activity in acute and chronic cardiac ischemic syndromes. Relationship to inflammation, complement activation and in vivo thrombin activity.
D'Angelo A; Gerosa S; D'Angelo SV; Mailhac A; Colombo A; Agazzi A; Mazzola G; Chierchia S
Thromb Res; 1994 Jul; 75(2):133-42. PubMed ID: 7974387
[TBL] [Abstract][Full Text] [Related]
20. Differences in protein S and C4b-binding protein levels in different groups of patients with antiphospholipid antibodies.
Forastiero RR; Kordich L; Basilotta E; Carreras LO
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):609-16. PubMed ID: 7841319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
